Company Filing History:
Years Active: 2002-2010
Title: Michael R. Myers: Innovator in Pharmacological Research
Introduction
Michael R. Myers is a distinguished inventor based in Saint Nom la Breteche, France. He has made significant contributions to the field of pharmacology, particularly in the development of treatments for neurological disorders. With a total of seven patents to his name, Myers has established himself as a key figure in pharmaceutical innovation.
Latest Patents
Among his latest patents, one notable invention is focused on the pharmacological uses of azetidine derivatives. This method aims to treat or prevent Alzheimer's disease, Parkinson's disease, and schizophrenia. The treatment involves administering a specific compound to patients in need. Another significant patent involves pharmaceutical compositions containing 3-aminoazetidine derivatives. This invention relates to the preparation and use of these compounds in treating various disorders of the nervous system.
Career Highlights
Michael R. Myers is currently associated with Aventis Pharma S.A., where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions for complex health issues, particularly those affecting the nervous system.
Collaborations
Throughout his career, Myers has collaborated with notable colleagues, including Daniel Achard and Jean Bouquerel. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in pharmacology.
Conclusion
Michael R. Myers exemplifies the spirit of innovation in the
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.